Travoprost/Verosudil

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTravoprost/Verosudil
Drug Alias NameTravoprost and VerosudilVerosudil and TravoprostAR-12286 and travoprostVerosudil/Travoprosttravoprost/AR-12286 +[7] 
ClassificationSmall molecules
Mechanisms of ActionProstanoid FP receptor agonistsRhodopsin kinase inhibitors
TargetsProstanoid FP receptorRhodopsin kinase
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes VerosudilTravoprost
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAerie Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAerie Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A